Cross-reference: "glucosamine" — FDA ADE reports ↔ evidence literature
A structural index linking the evidence layer (Europe PMC literature topics) and the FDA adverse-event (ADE) layer (openFDA animal-drug reports) by shared mention of the term "glucosamine". No new data was fetched; this topic is derived entirely from existing in-repo topics.
FDA ADE report topic
ade_glucosamine_adverse_events— FDA ADE reports for Glucosamine (active ingredient) — total reports, species & reaction breakdown
Evidence topics referencing "glucosamine"
evidence_equine_anhydrosis_diet— Horse — anhydrosis / heat & electrolyte management — dietary management (Europe PMC)evidence_equine_joint_arthritis_diet— Horse — joint health & arthritis (OA) — dietary management (Europe PMC)evidence_equine_senior_geriatric_feed— Pet horse — aged / senior / geriatric — diet & nutrition management (Europe PMC)evidence_joint_oa— Evidence cluster — osteoarthritis / joint supplements in dogs (peer-reviewed, Europe PMC)
Honest scope note
This is a term-co-occurrence cross-reference: the evidence topics above contain the term "glucosamine" in their text, and the ADE topic aggregates FDA adverse-event reports for that active ingredient. Co-occurrence is not a clinical assertion that the literature studies the drug's adverse events. Verify against the linked source topics before drawing conclusions.